Prediction of the risk of myocardial infarction from polymorphisms in candidate genes

New England Journal of Medicine

Volumn 347, Issue 24, 2002, Pages 1916-1923

  Yamada, Yoshiji ^a   Izawa, Hideo ^b   Ichihara, Sahoko ^b   Takatsu, Fumimaro ^c   Ishihara, Hitoshi ^d   Hirayama, Haruo ^e   Sone, Takahito ^f   Tanaka, Masashi ^a   Yokota, Mitsuhiro ^b,g  

^a GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ANJO KOSEI HOSPITAL   (Japan)

^d Okazaki City Hospital   (Japan)

^e NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^f OGAKI MUNICIPAL HOSPITAL   (Japan)

^g NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 37; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRIMER DNA; STROMELYSIN;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; COLORIMETRY; CONTROLLED STUDY; DIABETES MELLITUS; DNA DETERMINATION; FEMALE; FLUORESCENCE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING;

CASE-CONTROL STUDIES; CONNEXINS; DNA PROBES; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0037069779     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021445     Document Type: Article

References (22)

1. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-6.
2. Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation 1980;61:503-8.
3. Broeckel U, Hengstenberg C, Mayer B, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 2002;30:210-4.
4. Cambien F, Pokier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
5. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-4.
6. Iacoviello L, Di Castelnuovo A, de Knijff P, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998;338:79-85.
7. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N Engl J Med 1998;338:86-93.
8. Richard G, Lin J-P, Smith L, et al. Linkage studies in erythrokeratodermias: Fine mapping, genetic heterogeneity, and analysis of candidate genes. J Invest Dermatol 1997;109:666-71.
9. Boerma M, Forsberg L, van Zeijl L, et al. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 1999;246:211-8.
10. Yeh H-I, Chou Y, Liu H-F, Chang S-C, Tsai C-H. Connexin 37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 2001; 81:251-5.
11. Dinauer MC, Pierce EA, Bruns GAP, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22-phox): Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 1990;86:1729-37.
12. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998;97:135-7.
13. Guzik TJ, West NEJ, Black E, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000;102:1744-7.
14. phox, involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 2000;86:391-5.
15. Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen- activator 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A 1995;92:1851-5.
16. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation 1997;95:59-62.
17. Roest M, van der Schouw YT, Banga JD, et al. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 2000;101:67-70.
18. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: Genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 1995;73:209-15.
19. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996;271:13055-60.
20. Rauramaa R, Väisänen SB, Luong L-A, et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20: 2657-62.
21. Rundek T, Elkind MS, Pittman J, et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: The Northern Manhattan Prospective Cohort Study. Stroke 2002;33:1420-3.
22. Guetta V, Cannon RO III. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 1996;93:1928-37